Trial Profile
A study to evaluate safety and efficacy of Mirabegron in elderly patients with multiple co-morbidities compared to younger patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2016
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 12 Nov 2016 New trial record
- 16 Sep 2016 Results presented at the 46th Annual Meeting of the International Continence Society